Cargando…
The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may be associated with a higher thrombus burden. We performe...
Autores principales: | Bae, Ju Young, Hussein, Khalil Ian, Howes, Christopher John, Setaro, John Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379640/ https://www.ncbi.nlm.nih.gov/pubmed/34426772 http://dx.doi.org/10.1155/2021/9915650 |
Ejemplares similares
-
Challenges in managing ST elevation myocardial infarction during the COVID-19 pandemic
por: Smith, Megan, et al.
Publicado: (2021) -
Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic
por: Tam, Chor-Cheung Frankie, et al.
Publicado: (2021) -
COVID-19 mimicking ST-elevation myocardial infarction
por: Bujak, Kamil, et al.
Publicado: (2020) -
The Impact of COVID-19 on ST Elevation Myocardial Infarction
por: Femia, G., et al.
Publicado: (2021) -
Cocaine and COVID-19 in ST-Elevation Myocardial Infarction
por: Appenzeller, Florian, et al.
Publicado: (2022)